106 related articles for article (PubMed ID: 8578743)
1. Impact of immunosuppression caused by HIV infection on the replication of hepatitis C virus.
Soriano V; Bravo R; Mas A; García-Samaniego J; Guiérrez M; González-Lahoz J
Vox Sang; 1995; 69(3):259-60. PubMed ID: 8578743
[No Abstract] [Full Text] [Related]
2. Suppression of hepatitis C virus replication is maintained long term following HAART therapy, in an individual with HCV/HIV co-infection.
Torti C; Barnes E; Quiros-Roldan E; Puoti M; Carosi G; Klenerman P
Antivir Ther; 2004 Feb; 9(1):139-42. PubMed ID: 15040546
[No Abstract] [Full Text] [Related]
3. The evolution of occult Hepatitis C Virus after immunosuppression in advanced CKD patients.
Martín-Gómez MA; Castillo-Aguilar I; Barril-Cuadrado G; Cabezas-Fernández T; Casado-Martín M; Cabello-Díaz M
Nefrologia; 2015; 35(5):511-3. PubMed ID: 26306963
[No Abstract] [Full Text] [Related]
4. Influence of HTLV-2 infection on hepatitis C virus replication in HIV-positive patients.
Toro C; Bassani S; Ríos P; Jiménez V; Camino N; Soriano V
J Clin Virol; 2005 Apr; 32(4):338-9. PubMed ID: 15780816
[No Abstract] [Full Text] [Related]
5. Suppression of hepatitis C virus (HCV) replication by hepatitis D virus (HDV) in HIV-infected hemophiliacs with chronic hepatitis B and C.
Eyster ME; Sanders JC; Battegay M; Di Bisceglie AM
Dig Dis Sci; 1995 Jul; 40(7):1583-8. PubMed ID: 7628288
[TBL] [Abstract][Full Text] [Related]
6. Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters.
Beld M; Penning M; Lukashov V; McMorrow M; Roos M; Pakker N; van den Hoek A; Goudsmit J
Virology; 1998 May; 244(2):504-12. PubMed ID: 9601518
[TBL] [Abstract][Full Text] [Related]
7. Reactivation of HBV replication in HIV-HBV infected patients.
Bani-Sadr F; Maillard A; Ponscarme D; Scieux C; Molina JM
Am J Med; 2003 Jun; 114(9):768-9. PubMed ID: 12829207
[No Abstract] [Full Text] [Related]
8. Infectious disease. HIV therapy good for HCV infection.
Patman G
Nat Rev Gastroenterol Hepatol; 2014 Sep; 11(9):517. PubMed ID: 25092043
[No Abstract] [Full Text] [Related]
9. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.
Challine D; Buisson M; Cadilhac M; Germanidis G; Joab I; Eliaszewicz M; Caumes E; Flahault A; Fillet AM; Pawlotsky JM; Seigneurin JM
J Med Virol; 2002 Aug; 67(4):510-5. PubMed ID: 12115996
[TBL] [Abstract][Full Text] [Related]
10. Low cross-neutralization of hepatitis C correlates with liver disease in immunocompromized patients.
Maurin G; Halgand B; Bruscella P; Fresquet J; Duclos-Vallée JC; Roque-Afonso AM; Cosset FL; Samuel D; Lavillette D; Féray C
AIDS; 2015 Jun; 29(9):1025-33. PubMed ID: 26125137
[TBL] [Abstract][Full Text] [Related]
11. An effective interferon-gamma-mediated inhibition of hepatitis C virus replication by natural killer cells is associated with spontaneous clearance of acute hepatitis C in human immunodeficiency virus-positive patients.
Kokordelis P; Krämer B; Körner C; Boesecke C; Voigt E; Ingiliz P; Glässner A; Eisenhardt M; Wolter F; Kaczmarek D; Nischalke HD; Rockstroh JK; Spengler U; Nattermann J
Hepatology; 2014 Mar; 59(3):814-27. PubMed ID: 24382664
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic hepatitis C virus replication correlates with chronic hepatitis C disease severity in vivo.
Pal S; Shuhart MC; Thomassen L; Emerson SS; Su T; Feuerborn N; Kae J; Gretch DR
J Virol; 2006 Mar; 80(5):2280-90. PubMed ID: 16474135
[TBL] [Abstract][Full Text] [Related]
13. Interference of replication between hepatitis B and C viruses in patients infected with HIV.
Yang RR; Gui X; Chen XY; Zhu Y
J Med Virol; 2011 Jul; 83(7):1159-64. PubMed ID: 21567419
[TBL] [Abstract][Full Text] [Related]
14. Lessons from HIV and hepatitis viruses.
Sacks SL; Griffiths PD; Corey L; Cohen C; Cunningham A; Dusheiko GM; Self S; Spruance S; Stanberry LR; Wald A; Whitley RJ
Antiviral Res; 2004 Aug; 63 Suppl 1():S11-8. PubMed ID: 15450381
[TBL] [Abstract][Full Text] [Related]
15. Tritherapy for human immunodeficiency virus infection does not modify replication of hepatitis C virus in coinfected subjects.
Zylberberg H; Chaix ML; Rabian C; Rouzioux C; Aulong B; Bréchot C; Viard JP; Pol S
Clin Infect Dis; 1998 May; 26(5):1104-6. PubMed ID: 9597236
[TBL] [Abstract][Full Text] [Related]
16. Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era.
Maida I; Ríos MJ; Pérez-Saleme L; Ramos B; Soriano V; Pegram PS; Mura MS; Sánchez-Margalet V; Saldívar-Cornejo I; Wilkin A; Babudieri S; Núñez M
AIDS Res Hum Retroviruses; 2008 May; 24(5):679-83. PubMed ID: 18462085
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
[TBL] [Abstract][Full Text] [Related]
18. Determination of hepatitis C virus-infected, monocyte lineage reservoirs in individuals with or without HIV coinfection.
Coquillard G; Patterson BK
J Infect Dis; 2009 Sep; 200(6):947-54. PubMed ID: 19678757
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus coinfection does not affect CD4 restoration in HIV-infected patients after initiation of antiretroviral therapy.
Yacisin K; Maida I; Ríos MJ; Soriano V; Núñez M
AIDS Res Hum Retroviruses; 2008 Jul; 24(7):935-40. PubMed ID: 18593347
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy.
Vento S; Garofano T; Renzini C; Casali F; Ferraro T; Concia E
AIDS; 1998 Jan; 12(1):116-7. PubMed ID: 9456265
[No Abstract] [Full Text] [Related]
[Next] [New Search]
